Arrowstreet Capital
MR

Arrowstreet Capital’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Arrowstreet Capital’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,695
Closed -$594K – 1411
2014
Q3 		$594K Buy
+19,695
New +$610K ﹤0.01% 807

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Arrowstreet Capital's MR Position: Q4 2014 in Review

Arrowstreet Capital sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2014, closing a stake of 19,695 shares — an estimated $594K sold.

Arrowstreet Capital first reported a position in MR in Q3 2014 and held it in 1 quarter. The position peaked at $594K in Q3 2014. 137 funds tracked by Wall St. Rank hold MR as of Q4 2014.

  • Arrowstreet Capital reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2014 after selling out during the quarter.
  • Arrowstreet Capital sold 19,695 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2014, an estimated $594K.
  • Arrowstreet Capital first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2014 and held it in 1 quarter.
  • Arrowstreet Capital's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $594K in Q3 2014.
  • 137 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2014.

Based on Arrowstreet Capital's 13F filing for Q4 2014, filed 13 Feb 2015.